| Date | Title | Description |
| 10.09.2024 | CSA Medical's $53 Million Boost: A Breath of Fresh Air for Chronic Bronchitis Treatment | In the bustling world of medical innovation, CSA Medical has just made waves. The Boston-based company recently secured $53 million in Series D funding. This investment is not just a number; it represents hope for countless patients sufferi... |
| 09.09.2024 | CSA Medical Raises $53M in Series D Financing | RejuvenAir Metered Cryospray
CSA Medical, a Boston, Ma-based developer of The RejuvenAir® System, a medical device advancing liquid nitrogen spray cryotherapy for the treatment of chronic bronchitis, raised $53M in Series D funding.
The rou... |
| 09.09.2024 | CSA Medical: $53 Million (Series D) Raised For Advancing RejuvenAir System | CSA Medical, the developer of The RejuvenAir System (a Breakthrough Medical Device advancing the power of liquid nitrogen spray cryotherapy for the treatment of chronic bronchitis), announced the completion of an oversubscribed $53 million ... |
| 19.01.2015 | Azalea Health raises $1.5 million to help integrate SimplifyMD | He added that the Valdosta, Georgia health IT business, which got its start in 2008, would use the funding to continue to integrate SimplifyMD’s EHR and practice management software with its own admin services, such as a patient portal, bil... |
| 10.04.2013 | Advanced Animal Diagnostics Closes $6M Tranche of Series B Financing | Advanced Animal Diagnostics (AAD), a Durham, NC-based developer of on-farm diagnostics to improve animal health and productivity, closed a $6m tranche of Series B financing.
Backers included Intersouth Partners, Novartis Venture Funds and p... |
| 10.01.2013 | Investors have put $15.5M behind cancer drug startup to revive shelved Hsp90 inhibitor | Here’s what we’ve learned about Esanex since May: It’s apparently a resurrection of Serenex, a North Carolina-based cancer drug company that was acquired by Pfizer in 2008 when it was in phase 1 development. Several former Serenex executive... |
| 03.10.2012 | Biotech company developing therapies for macular edema raises $40 million | Solution/Product: The company makes the Iluvien drug delivery system that is implanted at the back of the eye and is designed to release sub-microgram levels of fluocinolone acetonide for up to 36 months to treat chronic diabetic macular ed... |
| 06.04.2012 | Nanotechnology investing: What VCs, angels and strategic investors look for | Focus. Harris & Harris (NASDAQ:TINY), a publicly traded venture firm that focuses on early stage nanotechnology investments, has done deals with a lot of companies that have platform technologies, said Doug Jamison, the firm’s CEO. But ... |
| 02.03.2012 | Adaptivity Raises $3.0M in Series B Venture Capital Financing | Adaptivity, The IT Blueprint Company™, a Charolotte, NC-based company that provides an intelligent IT blueprinting software suite, has closed the second $3.0m tranche of its Series B venture capital financing.
Backers include existing inves... |
| 14.11.2011 | simplifyMD Raises $4.5M Series A Funding | simplifyMD, an Alpharetta, GA-based electronic health records (EHR) provider, has raised a $4.5m Series A funding.
The round was led by Intersouth Partners.
The company intends to use the funds to to build out its sales team (http://www.sim... |
| 18.10.2011 | Row Sham Bow launches Woodland Heroes game for Facebook | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more.
Hope springs eternal for new social game companies. Row Sham Bow, a social game company based in Orlando, Fla., is launching its new so... |
| 14.10.2011 | How Steve Jobs’ example could spark health and life sciences innovation | But healthcare does have visionary leaders. Sam Taylor, president of the North Carolina Bioscience Organization suggests Craig Venter, the biologist and entrepreneur who might best be known for being the first to sequence the human genome. ... |
| 13.04.2011 | RTP venture capital climate improved in Q1 but biotechs still clamor for cash | Promoted
Clinical Care Capacity Planning
Learn how to manage clinical care capacity more efficiently during uncertain times.
SAP
Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems strive to recov... |
| 16.03.2011 | Diagnostics company AAD raises $11 million B round | Diagnostic device company Advanced Animal Diagnostics has secured $11 million in a series B round, which the company will pour into continued research and development of a detection tool for mastitis in dairy cows.
The round was led by Inte... |
| 15.03.2011 | NC diagnostics device company AAD raises $11M in series B round | Promoted
Covid-19’s terrible toll on diabetes patients. What can be done?
The public health crisis has undermined the economy and made people with chronic conditions more vulnerable and stressed. Learn more with a new report from Omada Heal... |
| 04.12.2007 | LA Times invests in Mixx, integrates social news site | Updated
The Los Angeles Times has partnered with Mixx, a social news website, to give readers more input in the news they read.
The publication has also said it will start using technology from Aggregrate Knowledge, a Silicon Valley company... |
| 26.06.2007 | Argolyn draws on $16M for neurological drugs | Argolyn Bioscience, a Charleston, S.C.-based developer of drugs for neurological problems, raised $15.8 million in a first financing round. The funding was led by Intersouth Partners and Quaker BioVentures, joined by Amgen Ventures.
Argolyn... |
| 07.06.2007 | Viamet raises $4M for metalloenzyme-targeting drugs | Research Triangle Park, N.C.-based Viamet raised $4 million in a first round of funding. The round was co-led by Hatteras Venture Partners and Intersouth Partners.
Viamet is developing drugs that target metalloenzymes — a diverse group of c... |
| 29.05.2007 | Biolex Therapeutics raises $30M for multiple-sclerosis treatment | Biolex Therapeutics, a Pittsboro, N.C., developer of technology for improving the properties of monoclonal antibodies, raised $30 million in a third funding round.
Biolex specializes in producing proteins that are difficult to make with exi... |
| - | Nanotechnology investing: What VCs, angels and strategic investors look for | As nanotechnology finds new uses ranging from engineering to medicine, a growing number of early stage companies are forming to bring new nanotech innovation into those markets.
But nanotech companies are clamoring for financing at a time w... |
| - | How Steve Jobs’ example could spark health and life sciences innovation | Steve Jobs turned around Apple (NASDAQ:AAPL) and in so doing, revolutionized how millions use technology in their lives. So is there a Steve Jobs for healthcare or the life sciences?
The short answer is “no.” High tech and life sciences thr... |
| - | Investors have put $15.5M behind cancer drug startup to revive shelved Hsp90 inhibitor | A cancer pharmaceutical startup called Esanex generated lots of reader interest back in May when it began raising a $15 million round.
The latest U.S. Security and Exchange Commission filing from Esanex (in December) shows that the round wa... |
| - | Azalea Health raises $1.5 million to help integrate SimplifyMD | One area of digital health where consolidation will continue to increase is the realm of cloud based services for physician practices. That includes apps tied to all the usual admin tools from billing to scheduling to prior authorization.
O... |
| - | Biotech company developing therapies for macular edema raises $40 million | Alimera Sciences, a public company without any revenue, has developed a drug delivery system to be implanted at the back of the eye and has raised $40 million through a private placement with institutional investors, both new and existing. ... |
| - | RTP venture capital climate improved in Q1 but biotechs still clamor for cash | Early stage life science companies still developing their technologies can fall into a gap: too expensive to be supported by more grants or angel investments yet not far enough along to secure venture capital interest.
In the worst economy ... |
| - | NC diagnostics device company AAD raises $11M in series B round | Diagnostic device company Advanced Animal Diagnostics has secured $11 million in a series B round of equity financing that the company will pour into continued research and development of a detection tool for mastitis in dairy cows.
The rou... |